Atıf İçin Kopyala
ÇETİN SORKUN H., Akbulut M., ENLİ Y., TEPELİ E., ÖZKAN S., ERDEM E.
TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.46, sa.1, ss.219-227, 2016 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
46
Sayı:
1
-
Basım Tarihi:
2016
-
Doi Numarası:
10.3906/sag-1411-158
-
Dergi Adı:
TURKISH JOURNAL OF MEDICAL SCIENCES
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
-
Sayfa Sayıları:
ss.219-227
-
Anahtar Kelimeler:
Midkine, breast cancer, serum, immunohistochemistry, real-time quantitative PCR, ELISA, EMBRYONAL CARCINOMA-CELLS, IN-SITU HYBRIDIZATION, PLEIOTROPHIN EXPRESSION, MOUSE EMBRYOGENESIS, MIDGESTATION PERIOD, PROGNOSTIC MARKER, GENE-EXPRESSION, TUMOR, DIFFERENTIATION, SURVIVAL
-
Akdeniz Üniversitesi Adresli:
Evet
Özet
Background/aim: Midkine (MK), a heparin-binding growth factor, has an important role in cancer progression. The aim of this study was to determine MK expression in breast tissue and the preoperative and postoperative serum levels of patients with breast cancer.